39 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
agreement with K2HV, a healthcare-focused specialty finance company, which provides Oncorus with up to $45 million available in multiple tranches upon
8-K
EX-99.1
rno9y 7pub
4 May 22
Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates
7:15am
8-K
EX-99.1
pokfk6 3nmjgl
5 Apr 22
Entry into a Material Definitive Agreement
7:10am
8-K
EX-10.1
fgzqv 2k1aw4w0z
19 Nov 21
Entry into a Material Definitive Agreement
4:47pm
DEF 14A
pggoj8yy kla
28 Apr 21
Definitive proxy
4:06pm
10-K
y5m5ybvo6xheq3561
10 Mar 21
Annual report
4:12pm
424B4
qim3agg9hq4ppgx
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
dcmlua y0w
28 Jan 21
Draft registration statement
12:00am
DRS
EX-10.12
mg08vaqv
28 Jan 21
Draft registration statement
12:00am